10.30-11.30am, Mon 25th June 2018
Seminar Room 515, Level 5, 207 Bouverie Street, Carlton
Rodica Stan, PhD, Centre for Gene Therapy, City of Hope, Duarte, California, U.S.A.
We developed a novel therapeutic strategy for HIV-1 infection by engineering HIV-resistant immune cells via gene editing of autologous hematopoietic stem/progenitor cells (HSPC). Continue reading “CEB WIP Seminar: 25th June 2018 – First-In-Human Study Of Feasibility And Safety Of Ccr5-Modified Blood Stem Cells In Hiv-1 Infected Subjects”